Antimicrobial-resistant bacteria are everywhere, especially in low-income areas. But how much do people know about the risks? Researchers in Malawi set out to find out. They talked to people from cities, towns near cities, and rural areas. They wanted to know what people thought about getting infect
On Tuesday, South Korean stocks took a hit in U. S. trading after President Yoon Suk Yeol declared emergency martial law. He said this step was needed to protect the country from "communist forces" amid debates over a budget bill in parliament. The iShares MSCI South Korea ETF, which tracks large an
President-elect Donald Trump has chosen Kash Patel, a former staffer and right-wing media personality, to head the FBI. This decision has attracted attention, with some questioning Patel's suitability for the role and the tradition of keeping the FBI director non-partisan. Patel, author of "Governme
You know how sometimes it's hard to tell who has ADHD and who doesn't just by looking at their brain? That's because the brain measures of kids with ADHD and those without can overlap a lot. But what if we could make these differences stand out more? That's where a risk-informed design comes in. Res
Bitcoin is getting closer to hitting $100, 000, with its price reaching $99, 645 on November 22. However, it hasn't been able to push past this milestone yet. Recently, Bitcoin had a brief dip to around $92, 500 but has since bounced back to around $96, 000. This recent rise is thanks to increased i
President Joe Biden's pardon for Hunter Biden was no surprise. Biden loves his family, so a pardon was expected. But here's what's interesting: we might be stepping into a new age of pardons. Imagine if former President Donald Trump gets his way. He wants to stop what he calls "lawfare, " or using
Religions can shape how people perceive and connect with their bodies. Researchers looked into how various aspects of religiosity influence interoceptive sensibility (IS), which is our ability to notice and understand bodily signals. They examined Christians, Muslims, and Hindus. Study 1 showed that
Poly(ADP-ribose) polymerase inhibitors, or PARPi, are powerful tools in the fight against cancer. However, not all tumors respond to them, even if they have issues with BRCA1/2 genes or homologous recombination. This is where a natural substance called NADP+ comes into play. It can make cancer cells
Ever wondered how a biosimilar drug, like adalimumab-adbm, measures up to its reference product, adalimumab RP? This analysis dives into the immunogenicity of both medicines in patients dealing with rheumatoid arthritis (RA), Crohn's disease (CD), and chronic plaque psoriasis (PsO). Known as the VOL
As the new legislative session starts in California, leaders like Senate President Pro Tem Mike McGuire and Assembly Speaker Robert Rivas are gearing up to address affordability issues that have been bothering voters. They plan to do this by building more housing, making energy cheaper, and improvin
